Dr. Arbour on the Latest Data for Checkpoint Inhibitors for Lung Cancer in 2019

June 11, 2019
Kathryn Cecilia Arbour, MD

Cancer Network spoke with Kathryn Cecilia Arbour, MD, of Memorial Sloan-Kettering Cancer Center, about the most recent research on checkpoint inhibitors in oncology.

Cancer Network spoke with Kathryn Cecilia Arbour, MD, medical oncologist at Memorial Sloan-Kettering Cancer Center, about the most recent research on checkpoint inhibitors in the treatment of cancer. Dr. Arbour presented this data during an educational session at ASCO 2019.

Related Content:

ASCO Lung Cancer | Lung Cancer